DE69209083D1 - System zur peroralen arzneimittelabgabe - Google Patents

System zur peroralen arzneimittelabgabe

Info

Publication number
DE69209083D1
DE69209083D1 DE69209083T DE69209083T DE69209083D1 DE 69209083 D1 DE69209083 D1 DE 69209083D1 DE 69209083 T DE69209083 T DE 69209083T DE 69209083 T DE69209083 T DE 69209083T DE 69209083 D1 DE69209083 D1 DE 69209083D1
Authority
DE
Germany
Prior art keywords
pct
therapeutic agent
reservoir
ionized
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69209083T
Other languages
English (en)
Other versions
DE69209083T2 (de
Inventor
Arto Olavi Urtti
Maria Riitta Sutinen
Timo Petteri Paronen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORION-YHTYMA OY, ESPOO, FI
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919121964A external-priority patent/GB9121964D0/en
Priority claimed from GB919123372A external-priority patent/GB9123372D0/en
Application filed by Individual filed Critical Individual
Publication of DE69209083D1 publication Critical patent/DE69209083D1/de
Application granted granted Critical
Publication of DE69209083T2 publication Critical patent/DE69209083T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Sludge (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69209083T 1991-10-16 1992-10-15 System zur peroralen arzneimittelabgabe Expired - Fee Related DE69209083T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919121964A GB9121964D0 (en) 1991-10-16 1991-10-16 Peroral drug delivery system
GB919123372A GB9123372D0 (en) 1991-11-04 1991-11-04 Peroral drug delivery system
PCT/FI1992/000274 WO1993007858A1 (en) 1991-10-16 1992-10-15 Peroral drug delivery system

Publications (2)

Publication Number Publication Date
DE69209083D1 true DE69209083D1 (de) 1996-04-18
DE69209083T2 DE69209083T2 (de) 1996-08-14

Family

ID=26299700

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69209083T Expired - Fee Related DE69209083T2 (de) 1991-10-16 1992-10-15 System zur peroralen arzneimittelabgabe

Country Status (9)

Country Link
US (1) US5518737A (de)
EP (1) EP0608306B1 (de)
JP (1) JPH07500110A (de)
AT (1) ATE135203T1 (de)
AU (1) AU661726B2 (de)
CA (1) CA2120748A1 (de)
DE (1) DE69209083T2 (de)
NO (1) NO307125B1 (de)
WO (1) WO1993007858A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
DE10000823A1 (de) * 2000-01-12 2001-07-19 Hartwin Hobler Einbringen von Gasen in eine Körperflüssigkeit
US7803148B2 (en) * 2006-06-09 2010-09-28 Neurosystec Corporation Flow-induced delivery from a drug mass
WO2008011125A2 (en) * 2006-07-20 2008-01-24 Neurosystec Corporation Devices, systems and methods for ophthalmic drug delivery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4756710A (en) * 1985-04-05 1988-07-12 Merck & Co., Inc. pH-Mediated drug delivery system
IT1204914B (it) * 1987-03-06 1989-03-10 Bonapace & C Spa Procedimento pe la protezione di sostanze poco stabili con miscele polimeriche e processi per la loro applicazione
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
JP2827287B2 (ja) * 1988-07-05 1998-11-25 武田薬品工業株式会社 水溶性薬物含有徐放型マイクロカプセル
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat

Also Published As

Publication number Publication date
AU2773292A (en) 1993-05-21
ATE135203T1 (de) 1996-03-15
NO941351D0 (no) 1994-04-14
NO941351L (no) 1994-04-14
CA2120748A1 (en) 1993-04-29
DE69209083T2 (de) 1996-08-14
EP0608306B1 (de) 1996-03-13
EP0608306A1 (de) 1994-08-03
JPH07500110A (ja) 1995-01-05
US5518737A (en) 1996-05-21
WO1993007858A1 (en) 1993-04-29
AU661726B2 (en) 1995-08-03
NO307125B1 (no) 2000-02-14

Similar Documents

Publication Publication Date Title
DK0764020T3 (da) Transdermalt system til indgivelse af lægemiddel
ES2053339T3 (es) Dispositivo dispensador conteniendo un medio hidrofobo.
DK0695172T3 (da) Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse
TR199700930T2 (xx) Ereksiyon bozuklu�unu �nlemek i�in y�ntem ve kit.
ATE298259T1 (de) Vorrichtung zur lokalen verabreichung einer arznei in einer körperhöhle
ES2157953T3 (es) Dispositivo de administracion por rotura osmotica activada por el ph.
DE50000750D1 (de) Implantat
DK0711146T3 (da) Osmotisk anordning med en vandpermeabel coating
DK0779807T3 (da) Fremgangsmåde til fremstilling af en kappetablet med spids kerne
DE60019116D1 (de) Neue omeprazole und (s)-omeprazole zusammensetzung
NO970610L (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
IE882898L (en) Solubility modulated drug delivery device
DE69209083D1 (de) System zur peroralen arzneimittelabgabe
EP1080709A3 (de) Absorbierender Artikel
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
RS49520B (sr) Antimikrobno aktivne smeše
DE3480826D1 (de) System zur gesteuerten freisetzung.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ORION-YHTYMA OY, ESPOO, FI

8381 Inventor (new situation)

Free format text: ERFINDER IST ANMELDER

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee